136 related articles for article (PubMed ID: 20057486)
1. Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.
Ishizaka N; Hongo M; Matsuzaki G; Furuta K; Saito K; Sakurai R; Sakamoto A; Koike K; Nagai R
Hypertens Res; 2010 Mar; 33(3):263-8. PubMed ID: 20057486
[TBL] [Abstract][Full Text] [Related]
2. Reversal of elevated cardiac expression of TGFbeta1 and endothelin-1 in OLETF diabetic rats by long-acting calcium antagonist.
Jesmin S; Zaedi S; Maeda S; Mowa CN; Sakuma I; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):907-12. PubMed ID: 16741022
[TBL] [Abstract][Full Text] [Related]
3. Comparison of vasculoprotective effects of benidipine and losartan in a rat model of metabolic syndrome.
Matsuzaki G; Ishizaka N; Furuta K; Hongo M; Saito K; Sakurai R; Koike K; Nagai R
Eur J Pharmacol; 2008 Jun; 587(1-3):237-42. PubMed ID: 18457832
[TBL] [Abstract][Full Text] [Related]
4. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
Jesmin S; Sakuma I; Hattori Y; Fujii S; Kitabatake A
Diabetologia; 2002 Mar; 45(3):402-15. PubMed ID: 11914746
[TBL] [Abstract][Full Text] [Related]
5. The calcium channel antagonist benidipine reduces plasma and cardiac endothelin-1 levels in type II diabetic rat model.
Jesmin S; Sakuma I; Hattori Y; Kitabatake A; Miyauchi T
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S49-53. PubMed ID: 15838356
[TBL] [Abstract][Full Text] [Related]
6. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
[TBL] [Abstract][Full Text] [Related]
7. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
[TBL] [Abstract][Full Text] [Related]
8. Chronic blockade of the angiotensin II receptor has a differential effect on adipose and vascular PAI-1 in OLETF rats.
Kim MJ; Lee DH; Park DB; Kang HW; An CS; Cui XJ; Kang JS; Kim JL; Lee YJ; Jung KW
Diabetes Res Clin Pract; 2006 Jul; 73(1):8-16. PubMed ID: 16413628
[TBL] [Abstract][Full Text] [Related]
9. Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats.
Okumura M; Masada M; Yoshida Y; Shintaku H; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Imanishi M
Kidney Int; 2006 Aug; 70(3):471-6. PubMed ID: 16775605
[TBL] [Abstract][Full Text] [Related]
10. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
[TBL] [Abstract][Full Text] [Related]
11. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
[TBL] [Abstract][Full Text] [Related]
12. Effect of losartan pretreatment on kidney lipid content after unilateral obstruction in rats.
Manucha W; Carrizo L; Alvarez S; Valles P; Oliveros L
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):539-45. PubMed ID: 16309578
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Matsumoto T; Kobayashi T; Kamata K
Eur J Pharmacol; 2006 May; 538(1-3):132-40. PubMed ID: 16678154
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
Hotta H; Miura T; Miki T; Togashi N; Maeda T; Kim SJ; Tanno M; Yano T; Kuno A; Itoh T; Satoh T; Terashima Y; Ishikawa S; Shimamoto K
Circ Res; 2010 Jan; 106(1):129-32. PubMed ID: 19910577
[TBL] [Abstract][Full Text] [Related]
15. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
16. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
Matsuura T; Yamagishi S; Kodama Y; Shibata R; Ueda S; Narama I
Int J Tissue React; 2005; 27(2):59-62. PubMed ID: 16035649
[TBL] [Abstract][Full Text] [Related]
17. Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus.
Sakano K; Takahashi M; Mutoh M; Niho N; Komiya M; Sato H; Tanaka T; Sugimura T; Wakabayashi K
Carcinogenesis; 2007 Oct; 28(10):2193-8. PubMed ID: 17510084
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats.
Matsumoto T; Ishida K; Nakayama N; Taguchi K; Kobayashi T; Kamata K
Pharmacol Res; 2010 Sep; 62(3):271-81. PubMed ID: 20304070
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus.
Bajotto G; Murakami T; Nagasaki M; Tamura T; Tamura N; Harris RA; Shimomura Y; Sato Y
Life Sci; 2004 Sep; 75(17):2117-30. PubMed ID: 15312755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
